Welcome to this Europe Biobank Week Congress Radio special. It recorded live from the Europe Biobank Week Congress that happened in Vienna, Austria from 14-17 May 2024.
The EBW Congress highlights cutting-edge biobanking innovations and research. Held over four days, it featured expert workshops, keynotes, over 85 oral and 140 poster presentations from across the biobanking community.
This episode features the State-of-the-Art speech delivered by Dr. Bo Franzén, Senior Researcher at Cancer Centre Karolinska of the Karolinska Institutet, during the Quality Management and Pre-Analytics session.
About Karolinska Institutet
Karolinska Institutet is one of the world’s leading medical universities. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
The tilte of Dr. Franzén’s talk is: ‘Minimally invasive fine needle aspiration-based molecular diagnostics in support of precision cancer medicine’ and it was delivered in the Hofburg’s Zeremoniensaal.
Resources
Karolinska Institutet: https://ki.se/en
Minimally invasive fine needle aspiration-based molecular diagnostics in support of precision cancer medicine: https://pubmed.ncbi.nlm.nih.gov/38519839/
Europe Biobank Week 2024 – Day Three: https://www.europebiobankweek.eu/ebw24live/ebw24-live-congress-radio-europe-biobank-week-2024-day-three/
Europe Biobank Week Podcasts: https://www.europebiobankweek.eu/tag/podcast/